These sessions are organized by industry partners and are separate from the official NordCoag 2026 scientific programme. Each session is limited to 25 participants. Registration links will be made available before the congress begins.
Day 1 – Wednesday, 16 September 2026
12:30 – 13:15
Novo Nordisk/TBD
Takeda/TBD
Day 2 – Thursday, 17 September 2026
08:00 – 08:45
Pfizer/From Trial to Treatment Centre: Marstacimab OLE Updates and Practical Insights from the Clinic
- 08.00-08.05 Welcome and introduction / Chair Maria Bruzelius
- 08.05-08.20 Presentation BASIS OLE study marstacimab / Professor Ana Boban, Head Haemophilia Centre, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Serbia
- 08.20-08.35 Patient cases and treatment experience with Hympavzi (marstacimab)/ Professor Florian Lange, Haemostasis Unit, Department of Internal Medicine II University Medical Center Hamburg‑Eppendorf, Hamburg, Germany
- 08.35-08.45 Discussion and closing remarks
12:20 – 13:05
Roche/TBD
Sobi/TBD
Day 3 – Thursday, 18 September 2026
08:00 – 08:45